Large-scale randomised controlled trials such as the STEP programme (semaglutide) and SCALE trials (liraglutide) reported pancreatitis as an uncommon adverse event (occurring in 0.1-1% of patients), with no clear signal for increased risk compared to placebo
The theory: improper Orange Book listing violates Section 5 of the FTC Act and, derivatively, supports treble damages under Section 2 of the Sherman Act
A daily 30 to 45 minute walk, particularly after meals, improves glucose disposal and insulin sensitivity in ways that complement GLP-1 agonist therapy
The evidence base for GLP-1 receptor agonists in treating binge eating disorder remains preliminary but promising
The effects of l-carnitine, acetyl-l-carnitine, and propionyl-l-carnitine on body mass in type 2 diabetes mellitus patients
How other peptides compare to semaglutide for heat sensitivity If you work with multiple peptides, understanding the relative heat sensitivity of each helps you prioritize your cold chain efforts